Drug Trial Radar · NCT01674621
Phase 2 Study of BA058 (Abaloparatide) Transdermal Delivery in Postmenopausal Women With Osteoporosis
Last checked: Nov 20, 2026Latest source record: Jun 16, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
250
Actual
Start
Sep 25, 2012
Primary completion
Aug 2, 2013
Study completion Aug 2, 2013
Sponsor
- Lead sponsor
- Radius Health, Inc.Industry
- Sponsor type
- Industry
- Collaborators
- Nordic Bioscience A/S
- First posted
- Aug 29, 2012
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- Female only, up to 85 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To determine the clinical safety and efficacy of abaloparatide transdermal in otherwise healthy postmenopausal women with osteoporosis as assessed by changes in bone mineral density (BMD) and serum markers of bone metabolism when compared to transdermal placebo and abaloparatide injection for 6 months of treatment.
Conditions
- Post Menopausal Osteoporosis
Interventions
Abaloparatide Transdermal (50 mcg)Drug
Abaloparatide Transdermal Microneedle Active Patch
Abaloparatide Transdermal (100 mcg)Drug
Abaloparatide Transdermal Microneedle Active Patch
Abaloparatide Transdermal (150 mcg)Drug
Abaloparatide Transdermal Microneedle Active Patch
Abaloparatide Injection (80 mcg)Drug
Abaloparatide Subcutaneous Injection
Abaloparatide PlaceboDrug
Abaloparatide Transdermal Microneedle Placebo Patch
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percent Change From Baseline in Bone Mineral Density (BMD) of Lumbar Spine at 6 MonthsTime frame: Baseline, 6 Months
Locations
9 sites in 4 countries. Site status is shown where the registry gives one.
Site not named
Lakewood, Colorado
Site not named
Atlanta, Georgia
Site not named
Bethesda, Maryland
Site not named
Aalborg, Denmark
Site not named
Ballerup Municipality, Denmark
Site not named
Vejle, Denmark
Site not named
Tallinn, Estonia
Site not named
Lodz, Poland
Site not named
Warsaw, Poland
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.